BioSpace News Archive

Advaxis, Inc. today announces its financial results for the third quarter ended July 31, 2021 and provides a business update.

Aileron Therapeutics today announced two upcoming poster presentations at the European Society of Medical Oncology (ESMO) Virtual Congress 2021, which is being held September 16-21, 2021.

Petros Pharmaceuticals, Inc. announces today that President and Chief Commercial Officer Fady Boctor will present at the H.C. Wainwright Global Investment Conference, which is being held virtually from September 13 – 15, 2021.

Gemini Therapeutics, Inc. today announced one oral presentation and the presentation of three posters at the 13th International Conference on Complement Therapeutics held in Ioannina, Greece from September 8-13, 2021.

Applied UV, Inc. (NASDAQ:AUVI) (“Applied UV” or the “Company”), announced that Q Saeed, CEO of Applied UV, will present at the virtual H.C. Wainwright Global Investor Conference.

WithHealth, Inc. (the “Company”), a precision concierge care telehealth company for employers and their employees, is ready to assist employers as they work to meet the new vaccine and testing requirements announced by the Biden administration.

Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS), today announced that senior management will present at the 23rd Annual H.C. Wainwright Global Investment Conference. The presentation will be made available at 7 a.m. ET on Tuesday, September 14, 2021, during the virtual conference.

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today the engagement of Venvalo Group to assist the Company on regulatory, strategic, and implementation aspects of the recently FDA-cleared Phase III clinical trial assessing ability of JadiCells to treat patients with advanced COVID-19.

Sunovion Pharmaceuticals Inc. (Sunovion) today announced the presentation of multiple posters highlighting KYNMOBI® (apomorphine sublingual film) for the on-demand treatment of OFF episodes associated with Parkinson’s disease (PD) at the International Parkinson and Movement Disorder Society (MDS) Virtual Congress, being held September 17-22, 2021.

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it will present new data from its movement disorder treatments for tardive dyskinesia (TD) and Parkinson’s disease at the International Parkinson and Movement Disorder Society’s (MDS) Virtual Congress 2021 being held September 17–22, 2021.